{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:01:35Z","timestamp":1790715695011,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cardiovascular disease have been studied extensively. However, it remains unclear to what extent n-3 PUFAs may impact Reverse Cholesterol Transport (RCT). RCT describes a mechanism by which excess cholesterol from peripheral tissues is transported to the liver for hepatobiliary excretion, thereby inhibiting foam cell formation and the development of atherosclerosis. The aim of this review is to summarize the literature and to provide an updated overview of the effects of n-3 PUFAs on key players in RCT, including apoliprotein AI (apoA-I), ATP-binding cassette transporter A1 (ABCA1), ABCG1, apoE, scavenger receptor class B type I (SR-BI), cholesteryl ester transfer protein (CETP), low-density lipoprotein receptor (LDLr), cholesterol 7 alpha-hydroxylase (CYP7A1) and ABCG5\/G8. Based on current knowledge, we conclude that n-3 PUFAs may beneficially affect RCT, mainly by influencing high-density lipoprotein (HDL) remodeling and by promoting hepatobiliary sterol excretion.<\/jats:p>","DOI":"10.3390\/nu9101099","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T10:56:34Z","timestamp":1507287394000},"page":"1099","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review"],"prefix":"10.3390","volume":"9","author":[{"given":"Alex","family":"Pizzini","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Lunger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egon","family":"Demetz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hilbe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Ebenbichler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Tancevski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2017). The Top 10 Causes of Death, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9149(03)00615-5","article-title":"Regulation of reverse cholesterol transport and clinical implications","volume":"92","author":"Rader","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-61-5-888","article-title":"Risk Factors in Coronary Heart Disease: An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease: The Framingham Study","volume":"61","author":"Kannel","year":"1964","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular M\u00fcnster (PROCAM) Study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/HCO.0000000000000211","article-title":"HDL-cholesterol and cardiovascular disease: rethinking our approach","volume":"30","author":"Siddiqi","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","article-title":"Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit","volume":"85","author":"Badimon","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","article-title":"Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice","volume":"100","author":"Tangirala","year":"1999","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","article-title":"Cardiovascular disease risk reduction by raising HDL cholesterol\u2014Current therapies and future opportunities","volume":"167","author":"Wonnerth","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1161\/CIR.0000000000000482","article-title":"Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease","volume":"135","author":"Siscovick","year":"2017","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 Fatty Acids and Cardiovascular Disease","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s11745-012-3708-8","article-title":"Decreased plasma cholesterol concentrations after PUFA-rich diets are not due to reduced cholesterol absorption\/synthesis","volume":"47","author":"Ramprasath","year":"2012","journal-title":"Lipids"},{"key":"ref_14","first-page":"87","article-title":"N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia","volume":"33","author":"Vecka","year":"2012","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, F., Wang, Y., Zhu, Y., Liu, X., Xia, H., Yang, X., and Sun, G. (2016). Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: A randomized, double-blind, placebo-controlled trial. Eur. J. Nutr.","DOI":"10.1007\/s00394-016-1352-4"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1520-765X(01)90105-1","article-title":"The role of the exogenous pathway in hypercholesterolaemia","volume":"3","author":"Shepherd","year":"2001","journal-title":"Eur. Hear. J. Suppl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MOL.0b013e32833dedaa","article-title":"Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions","volume":"21","author":"Zhao","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and Atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajcn\/77.2.300","article-title":"Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity","volume":"77","author":"Chan","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M200282-JLR200","article-title":"Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance","volume":"44","author":"Park","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/diabetes.51.8.2377","article-title":"Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subjects With Dyslipidemia","volume":"51","author":"Chan","year":"2002","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39i","DOI":"10.1016\/j.amjcard.2005.12.026","article-title":"Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids","volume":"98","author":"Robinson","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.2174\/138161209789909773","article-title":"The Role of Polyunsaturated Fatty Acids (PUFA) in the Treatment of Dyslipidemias","volume":"15","author":"Zuliani","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1161\/ATVBAHA.109.187252","article-title":"Fish Oil Promotes Macrophage Reverse Cholesterol Transport in Mice","volume":"29","author":"Nishimoto","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.plefa.2014.05.002","article-title":"The effect of dietary omega-3 polyunsaturated fatty acids on plasma lipids and lipoproteins of C57BL\/6 mice is age and sex specific","volume":"91","author":"Balogun","year":"2014","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kasbi Chadli, F., Nazih, H., Krempf, M., Nguyen, P., and Ouguerram, K. (2013). Omega 3 Fatty Acids Promote Macrophage Reverse Cholesterol Transport in Hamster Fed High Fat Diet. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061109"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moss, J.W.E., Davies, T.S., Garaiova, I., Plummer, S.F., Michael, D.R., and Ramji, D.P. (2016). A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151057"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2011.03.001","article-title":"ATP-binding cassette transporter A1 and HDL metabolism: Effects of fatty acids","volume":"23","author":"Lee","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Xie, X., Zhang, T., Zhao, S., Li, W., Ma, L., Ding, M., and Liu, Y. (2016). Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats. Lipids Health Dis., 15.","DOI":"10.1186\/s12944-016-0250-3"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tanaka, N., Irino, Y., Shinohara, M., Tsuda, S., Mori, T., Nagao, M., Oshita, T., Mori, K., Hara, T., and Toh, R. (2017). Eicosapentaenoic Acid-Enriched High-Density Lipoproteins Exhibit Anti-Atherogenic Properties. Circ. J.","DOI":"10.1253\/circj.CJ-17-0294"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.atherosclerosis.2014.10.011","article-title":"Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia","volume":"237","author":"Tanaka","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/bi9013227","article-title":"ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I","volume":"49","author":"Gaidukov","year":"2010","journal-title":"Biochemistry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/1947-2714.103310","article-title":"Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases","volume":"4","author":"Litvinov","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"F\u00fcl\u00f6p, P., Harangi, M., Seres, I., and Paragh, G. (2016). Paraoxonase-1 and adipokines: Potential links between obesity and Atherosclerosis. Chem. Biol. Interact.","DOI":"10.1016\/j.cbi.2016.04.003"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1476-511X-11-116","article-title":"Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome","volume":"11","author":"Burillo","year":"2012","journal-title":"Lipids Health Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.freeradbiomed.2012.01.019","article-title":"Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages","volume":"52","author":"Berrougui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"36091","DOI":"10.1074\/jbc.M602247200","article-title":"ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions","volume":"281","author":"Landry","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M704590200","article-title":"Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles","volume":"282","author":"Vedhachalam","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7150\/ijbs.5.474","article-title":"Lipoproteins, cholesterol homeostasis and cardiac health","volume":"5","author":"Daniels","year":"2009","journal-title":"Int. J. Biol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.R039297","article-title":"Cardioprotective functions of HDLs","volume":"55","author":"Rye","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/ATVBAHA.107.142455","article-title":"Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1","volume":"27","author":"Mulya","year":"2007","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2016.01.002","article-title":"Eicosapentaenoic acid membrane incorporation impairs ABCA1-dependent cholesterol efflux via a protein kinase A signaling pathway in primary human macrophages","volume":"1861","author":"Fournier","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2006.04.018","article-title":"Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR\/RXR responsive element","volume":"191","author":"Uehara","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"30150","DOI":"10.1074\/jbc.M505368200","article-title":"ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins","volume":"280","author":"Vaughan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaranarayanan","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_50","first-page":"176","article-title":"Effect of eicosapentaenoic acid on the expression of ABCG1 gene in the human monocyte THP-1 cells","volume":"52","author":"Doosti","year":"2014","journal-title":"Acta Med. Iran."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/156720511796391926","article-title":"Dietary Omega 3 polyunsaturated fatty acids and Alzheimer\u2019s disease: Interaction with apolipoprotein E genotype","volume":"8","author":"Samieri","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.60.7.940","article-title":"Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.410420514","article-title":"Dietary fat intake and the risk of incident dementia in the Rotterdam Study","volume":"42","author":"Kalmijn","year":"1997","journal-title":"Ann. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/138161208783497769","article-title":"Apolipoprotein E knockout models","volume":"14","author":"Kolovou","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2008.08.021","article-title":"Impact of feeding polyunsaturated fatty acids on cholesterol metabolism of dyslipidemic obese rats of WNIN\/GR-Ob strain","volume":"204","author":"Sheril","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lambert, C., Cubedo, J., Padr\u00f3, T., S\u00e1nchez-Hern\u00e1ndez, J., Antonijoan, R.M., Perez, A., and Badimon, L. (2017). Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study. Nutrients, 9.","DOI":"10.3390\/nu9060599"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Minihane, A.M. (2016). Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes. Nutrients, 8.","DOI":"10.3390\/nu8030123"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3945\/ajcn.114.103507","article-title":"Interaction between BMI and APOE genotype is associated with changes in the plasma long-chain-PUFA response to a fish-oil supplement in healthy participants","volume":"102","author":"Conway","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_59","first-page":"73","article-title":"Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation","volume":"6","author":"Thifault","year":"2013","journal-title":"J. Nutrigenet. Nutrigenom."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0002-9440(10)63341-X","article-title":"Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development","volume":"165","author":"Bos","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"20982","DOI":"10.1074\/jbc.272.34.20982","article-title":"Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux","volume":"272","author":"Ji","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1194\/jlr.M700200-JLR200","article-title":"SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL","volume":"49","author":"Pagler","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1194\/jlr.M600136-JLR200","article-title":"Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI","volume":"47","author":"Brundert","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1172\/JCI25327","article-title":"Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo","volume":"115","author":"Zhang","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5551\/jat.No1347","article-title":"High dietary n-6\/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1","volume":"16","author":"Zhang","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.abb.2015.11.002","article-title":"Eicosapentaenoic acid inhibits intestinal \u03b2-carotene absorption by downregulation of lipid transporter expression via PPAR-\u03b1 dependent mechanism","volume":"590","author":"Mashurabad","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jnutbio.2014.02.008","article-title":"Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene","volume":"25","author":"Raposo","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1194\/jlr.M500051-JLR200","article-title":"Lack of stimulation of cholesteryl ester transfer protein by cholesterol in the presence of a high-fat diet","volume":"46","author":"Cheema","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0958-1669(99)00030-0","article-title":"Peroxisome proliferator-activated receptors: Three isotypes for a multitude of functions","volume":"10","author":"Michalik","year":"1999","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.plefa.2013.01.001","article-title":"Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor","volume":"88","author":"Ishida","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1079\/BJN2002556","article-title":"Eicosapentaenoic acid and docosahexaenoic acid from fish oils: Differential associations with lipid responses","volume":"87","author":"Minihane","year":"2002","journal-title":"Br. J. Nutr."},{"key":"ref_74","unstructured":"Amanda Pepper-Yowell, M.S., Ballou, M., Trojan, S., Thompson, L., Moustaid-Moussa, N., Wang, S., and Sheridan, M. (2014). The Role Docosapentaenoic Acid Omega-3 Plays in Controlling Lipid Metabolism and Inflammation Associated with Obesity, Atherosclerosis, and Neurodegenerative Disease. [Ph.D. Thesis, Texas Tech University]."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-2275(20)30120-6","article-title":"Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice","volume":"43","author":"Vasandani","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI19197","article-title":"Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production","volume":"113","author":"Pan","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1073\/pnas.0707460104","article-title":"Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control","volume":"105","author":"Pan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000014762.06201.06","article-title":"Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?","volume":"105","author":"Steinberg","year":"2002","journal-title":"Circulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease","volume":"345","author":"Brown","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/01.ATV.0000034706.24149.95","article-title":"Antioxidant Vitamins and Lipid Therapy","volume":"22","author":"Brown","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-5793(04)00049-3","article-title":"Dietary fish oil up-regulates cholesterol 7\u03b1-hydroxylase mRNA in mouse liver leading to an increase in bile acid and cholesterol excretion","volume":"559","author":"Dumon","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_82","first-page":"459","article-title":"Intestinal cholesterol secretion: Future clinical implications","volume":"71","author":"Jakulj","year":"2013","journal-title":"Neth. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jnutbio.2009.02.010","article-title":"Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: No effect of monounsaturated nor saturated fatty acids","volume":"21","author":"Alvaro","year":"2010","journal-title":"J. Nutr. Biochem."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/10\/1099\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:46:40Z","timestamp":1760208400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/10\/1099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":83,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"alternative-id":["nu9101099"],"URL":"https:\/\/doi.org\/10.3390\/nu9101099","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}